Cantor Fitzgerald analyst Brett Knoblauch reiterated an Overweight rating on Strategy (NASDAQ: MSTR).The analyst commented, "Strategy (MSTR, OW) purchased 1,550 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE